Ruel Cedeno is the Head of Cheminformatics at Novalix, specializing in artificial intelligence and machine learning for drug discovery. He earned his PhD in Physics from the University of Aix-Marseille, where he received the Eiffel Excellence Award and the AMU-ED Best Thesis Prize. He has authored over 15 peer-reviewed publications at the intersection of computational and pharmaceutical sciences. At Novalix, he leads a team of computational chemists in close collaboration with medicinal chemists and DEL scientists. His expertise in computational drug discovery has been demonstrated not only through successful client projects but also by top performance in international AI/ML competitions, including the 2025 Antiviral Challenge and the DREAM DEL-ML Drug Discovery Challenge.